Trevi Therapeutics(TRVI) - 2025 Q4 - Earnings Call Transcript

Trevi Therapeutics (NasdaqGM:TRVI) Q4 2025 Earnings call March 17, 2026 04:30 PM ET Company ParticipantsAlexa Deemer - VP of Biotechnology Equity ResearchBrandon Folkes - Managing Director of Biopharma Biotechnology Equity ResearchDavid Hastings - CFODebanjana Chatterjee - VP of Healthcare ResearchFarrell Simon - Chief Commercial OfficerJames Cassella - Chief Development OfficerJayed Momin - Biopharma Equity Research AssociateJennifer Good - President and CEORyan Deschner - Equity Research AssociateConferen ...